Objective We assessed the effectiveness of PrismRA to improve clinical outcomes among patients with rheumatoid arthritis (RA) initiating treatment with a biologic or targeted synthetic disease‐modifying antirheumatic drug (b/tsDMARD). Methods PrismRA incorporated 19 gene expression features and four clinical features to assess a patient's likelihood of
Fenglong Xie +3 more
wiley +1 more source
Psychometric evaluation of Persian version of the oral presentation evaluation scale in nursing students. [PDF]
Rahmatkhah T +4 more
europepmc +1 more source
Rheumatologic Manifestations of Patients With Type B Insulin Resistance
Objective The objectives of this study were to identify laboratory and clinical features associated with type B insulin resistance (TBIR), a rare condition caused by autoantibodies that inhibit the insulin receptor, most frequently occurring in the setting of systemic lupus erythematosus (SLE), and to increase awareness of this rare, life‐threatening ...
S. Amara Ogbonnaya +4 more
wiley +1 more source
Perinatal Substance Use-Related Content at Major Addiction Scientific Conferences: An Analysis of Oral Presentation Sessions. [PDF]
Xu KY +7 more
europepmc +1 more source
Oral presentation assessment and image reading behaviour on brain computed tomography reading in novice clinical learners: an eye-tracking study. [PDF]
Liu CH +10 more
europepmc +1 more source
Oral Presentations and Poster Presentations
openaire +3 more sources
Objectives Systemic lupus erythematosus (SLE) is a heterogenous inflammatory condition, with widely varying global prevalence estimates. Frequency of SLE in the general population of Australia has been reported to be notably lower than contemporary estimates in countries such as the US or UK at 19‐39 per 100,000 as opposed to 65‐97 per 100,000.
Lucinda Roper +7 more
wiley +1 more source
Reliability of rubrics in the assessment of clinical oral presentation: A prospective controlled study. [PDF]
Moothedath M.
europepmc +1 more source
Oral Presentation Award Winner: Appropriateness of Antiplatelet Pretreatment in Non-ST-segment Elevation Acute Coronary Syndrome: Differences Between Unstable Angina and Acute Myocardial Infarction. [PDF]
Torres-Ruiz G +4 more
europepmc +1 more source

